FDA approves new drugs
·On Dec. 16, the U.S. Food and Drug Administration (FDA) approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.